Regulatory Harmony Needed To Fulfill Personalized Medicine Promise
This article was originally published in The Gray Sheet
Executive Summary
Barriers to reaching the full potential of personalized medicine diagnostics include low reimbursements, best methods to validate tests and physician education needs, as well as discordance between regulations for lab-developed tests and diagnostic test kits, witnesses told a House panel July 23.